All Insights

Sustainable disruption: 12 decarbonising technologies for cities

Sustainable disruption: 12 decarbonising technologies for cities

We need clean cities. They consume over two-thirds of global energy resources and account for more than 70% of CO2

Read time 2m
Life Sciences and Healthcare

UK sets out plans to diverge from EU regime on gene editing in plants

The UK government has published its response to a gene-editing consultation launched earlier this year, which sought views on the

Read time 4m
Life Sciences and Healthcare

The government has vision for the UK as the world's leading hub for life sciences

The prime minister, Boris Johnson, name checked a who's who of past British life science pioneers, including Edward Jenner, Ronald

Read time 5m
Life Sciences and Healthcare

Dealing with healthcare data: an overview of the key European markets

Handling health data can be a challenge. Depending on where you are based, you'll need to have a strong grasp


HMRC publishes call for evidence on simplifying the VAT land exemption

In March's Budget 2021, the chancellor announced that HMRC would look again at simplifying the value-added tax (VAT) rules for

Read time 3m
Life Sciences and Healthcare

Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries

On 5 May the US government unexpectedly swung behind the calls to waive intellectual property (IP) protections for Covid-19 vaccines

Life Sciences and Healthcare

Queen's Speech 2021 sets out ambitious agenda for UK life sciences and healthcare

This year's Queen Speech has laid out the government's vision for the UK after the pandemic, with the life sciences

Life Sciences and Healthcare

Patents Court upholds validity of second medical use patent for glaucoma treatment

The recent decision in Alcon v Accord & Aspire deals with a number of important patent law issues including novelty

Life Sciences and Healthcare

Support programmes offer global healthcare ways to meet patients' needs

The world faces a major healthcare challenge due to an ageing population and the increased prevalence of chronic disease and

Read time 5m
Life Sciences and Healthcare

UK government backs breakthrough tech with £375m future fund

The government's Future Fund, launched to support the UK’s innovative businesses affected by Covid-19, was an undoubted success providing over


UK passes new law allowing government intervention in transactions on national security grounds

The UK's National Security and Investment Act 2021 has completed its passage through Parliament and was passed into law on

Intellectual property

Would a global vaccine IP waiver stifle future biopharma breakthroughs?

The People's Vaccine Alliance, endorsed by 170 Nobel Laureates and former heads of state, in an open letter (14 April

Read time 7m